Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

Willemse EAJ, De Vos A, Herries EM, Andreasson U, Engelborghs S, van der Flier WM, Scheltens P, Crimmins D, Ladenson JH, Vanmechelen E, Zetterberg H, Fagan AM, Blennow K, Bjerke M, Teunissen CE.

Clin Chem. 2018 Mar 9. pii: clinchem.2017.283028. doi: 10.1373/clinchem.2017.283028. [Epub ahead of print]

PMID:
29523639
2.

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results.

Tijms BM, Willemse EAJ, Zwan MD, Mulder SD, Visser PJ, van Berckel BNM, van der Flier WM, Scheltens P, Teunissen CE.

Clin Chem. 2018 Mar;64(3):576-585. doi: 10.1373/clinchem.2017.281055. Epub 2017 Dec 5.

PMID:
29208658
3.

The use of cerebrospinal fluid in biomarker studies.

Teunissen CE, Verheul C, Willemse EAJ.

Handb Clin Neurol. 2017;146:3-20. doi: 10.1016/B978-0-12-804279-3.00001-0.

PMID:
29110777
4.

Detection of contactin-2 in cerebrospinal fluid (CSF) of patients with Alzheimer's disease using Fluorescence Correlation Spectroscopy (FCS).

Chatterjee M, Nöding B, Willemse EAJ, Koel-Simmelink MJA, van der Flier WM, Schild D, Teunissen CE.

Clin Biochem. 2017 Dec;50(18):1061-1066. doi: 10.1016/j.clinbiochem.2017.08.017. Epub 2017 Aug 30.

PMID:
28860054
5.

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ1-42, T-tau, and P-tau values.

Willemse EAJ, van Uffelen KWJ, van der Flier WM, Teunissen CE.

Alzheimers Dement (Amst). 2017 Apr 4;8:45-50. doi: 10.1016/j.dadm.2017.03.005. eCollection 2017.

6.

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design.

de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, Batrla-Utermann R, Scheltens P, Teunissen CE, van Berckel BN, van der Flier WM.

Alzheimers Dement (Amst). 2017 Jan 23;6:143-151. doi: 10.1016/j.dadm.2017.01.003. eCollection 2017.

7.

Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid.

Willemse EA, Durieux-Lu S, van der Flier WM, Pijnenburg YA, de Jonge R, Teunissen CE.

J Alzheimers Dis. 2016 Apr 21;53(1):107-16. doi: 10.3233/JAD-160061.

PMID:
27104901
8.

Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases.

Willemse EA, Teunissen CE.

Adv Exp Med Biol. 2015;864:79-93. doi: 10.1007/978-3-319-20579-3_7. Review.

PMID:
26420615
9.

Standard biobanking conditions prevent evaporation of body fluid samples.

Willemse EA, Koel-Simmelink MJ, Durieux-Lu S, van der Flier WM, Teunissen CE.

Clin Chim Acta. 2015 Mar 10;442:141-5. doi: 10.1016/j.cca.2015.01.036. Epub 2015 Feb 4. Erratum in: Clin Chim Acta. 2015 Jul 20;447:119-20.

PMID:
25661086

Supplemental Content

Loading ...
Support Center